神经干细胞及其在中枢神经创伤修复中的应用前景

被引:10
作者
徐如祥
姜晓丹
机构
[1] 第一军医大学珠江医院全军神经医学研究所神经外科
[2] 第一军医大学珠江医院全军神经医学研究所神经外科 广东广州
[3] 广东广州
关键词
神经干细胞; 神经损伤; 细胞移植; 神经损伤修复;
D O I
暂无
中图分类号
R651 [头部及神经外科学];
学科分类号
1002 ; 100210 ;
摘要
神经干细胞具有很强的增殖和分化能力,它已在中枢神经组织损伤修复方面展示了不可估量的临床应用前景。但是,目前有关神经干细胞的组织来源、定向诱导分化、移植技术和神经功能修复的功能判定等方面尚存在诸多难题。如何解决这些难题,并建立一个适合于临床中枢神经损伤修复的神经干细胞移植治疗技术平台是非常迫切的问题。本文着重就神经干细胞的来源、分化增殖调控、移植治疗技术及神经干细胞移植修复中枢神经组织损伤的可能机制等提出一些初步看法和展望。
引用
收藏
页码:4 / 7
页数:4
相关论文
共 29 条
[1]  
Direct isolation of human central nervous system stem cells. UchidaN,BuckDW,HeD,etal. Proceedings of the National Academy of Sciences of the United States of America . 2000
[2]  
Targeting of marrow-derived astrocytes to the ischemic brain. EglitisMA,DawsonD,ParkKW,etal. NeuroReport . 1999
[3]  
Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. RoyNS,WangS,Harrison-RestelliC,etal. The Journal of Neuroscience . 1999
[4]  
Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling. BerezovskaO,JackC,McLeanP,etal. Journal of Neurochemistry . 2000
[5]  
Embryonic stem cell lines derived from human blastocysts. ThomsonJA,Itskovitz-EldorJ,ShapiroS,etal. Science . 1998
[6]  
therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. ChenJ,LiY,WangL,etal. Stroke . 2001
[7]  
Growth factors inPakinson、s disease. UnsickerK. ProgGrowthFactorRes . 1994
[8]  
The human homolog of rat jagged1 expressed by marrow stroma inhibits differentiation of32D cells through interaction withNotch1. LiL,MilnerLA,DengY,etal. Immunity . 1998
[9]  
Stem cells[P]. 英国专利:GB0025088D0,2000-11-29
[10]  
Interastriatal transplantation of bone marrow stromal cells(MSCs) improves functional recovery after stroke in adult mice. LiY,ChoppM,ChenJ,etal. J CerebBloodFlowMetab . 2000